Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v6-EN Version v6-EN
Language English English
Date Updated 2020-01-08 2020-01-08
Drug Identification Number 02315181 02315181
Brand name PRO-RABEPRAZOLE PRO-RABEPRAZOLE
Common or Proper name PRO-RABEPRAZOLE PRO-RABEPRAZOLE
Company Name PRO DOC LIMITEE PRO DOC LIMITEE
Ingredients RABEPRAZOLE SODIUM RABEPRAZOLE SODIUM
Strength(s) 10MG 10MG
Dosage form(s) TABLET (ENTERIC-COATED) TABLET (ENTERIC-COATED)
Route of administration ORAL ORAL
Packaging size 100 100
ATC code A02BC A02BC
ATC description DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD) DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)
Reason for shortage Other (Please describe in comments) Other (Please describe in comments)
Anticipated start date 2019-12-31 2019-12-31
Actual start date 2020-01-07 2020-01-07
Estimated end date Unknown Unknown
Actual end date
Shortage status Actual shortage Actual shortage
Company comments Looking for an alternate source of supply. Recherche d'une nouvelle source d'approvisionnement. Looking for an alternate source of supply. Recherche d'une nouvelle source d'approvisionnement.
Health Canada comments